Orexo Signs an Exclusive Development Agreement for Its OX17 Program - WELT ONLINE

February 12, 2009 1:00 am acid reflux
Orexo Signs an Exclusive Development Agreement for Its OX17 Program
WELT ONLINE, Germany - Feb 8, 2009
Gastroesophageal reflux disease (GERD) is a chronic disease that causes recurrent acid reflux, commonly known as "heart burn.” Symptoms occur when acid …

Source:Orexo Signs an Exclusive Development Agreement for Its OX17 Program - WELT ONLINE

One Response

  1. Randall Says:
    April 27th, 2009 at 11:55 am

    Randall…

    …

Leave a Comment

Your comment

You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Please note: Comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.